As a global leader in developing and delivering generic medicines, Sandoz has a comprehensive offering both geographically and in portfolio terms, plus a range of value-added customer and patient services. We offer a broad portfolio covering all major therapeutic areas, resulting in substantial savings and improved access to healthcare.
In addition to the global #1 ranking in biosimilars and generic antibiotics, dermatology and transplantation medicines, we hold leading global positions in areas ranging from generic cardiovascular, central nervous system (CNS), pain and ophthalmology to oncology, respiratory and hormonal therapeutics.
Our broad portfolio of approximately 1 000 molecules is spearheaded by our global leadership position in biosimilars, the “cutting edge” of innovative off-patent medicines, as well as antibiotics, which are the foundation of global healthcare systems.
Sandoz is the pioneer and global leader in biosimilars – approved biologics with comparable quality, safety and efficacy to existing biologics that introduce much-needed competition into this critical area of modern medicine. In addition, as the global leader in generic antibiotics, we play a critical role in ensuring the sustainability of global healthcare systems. Antibiotics are the cornerstone of healthcare today. In addition to treating a wide range of infectious diseases, antibiotics are critical to guarantee patient safety during in-hospital medical procedures such as transplants.
Our broad offering translates into substantial and ongoing savings for patients and payors, which help to ensure the sustainability of healthcare systems in the face of significant budgetary pressures, while also freeing up funding for innovative medicines. Our products, which are sold in more than 160 countries, reach more than 500 million patients and our aspiration is to reach one billion.
At Sandoz, we make far more than just traditional generic medicines. Sandoz offers a variety of drug delivery mechanisms. These include:
Inhalables – used in the treatment of asthma and COPD, inhalables combine complex drugs with sophisticated medical devices
Injectables – non-biologic drugs taken via injection, which follow a parenteral route of administration. They are the cornerstone of modern hospital treatment and most typically include intradermal, subcutaneous, intramuscular and intravenous methods of application.
Oral solids – tablets or capsules; can be extended or slow release
Oral films – particularly effective for patients who need fast acting treatment or who have difficulties swallowing oral medications
Transdermal patches – an innovative alternative for controlled drug delivery through the skin and into the bloodstream